News

Opinion
Zacks Investment Research on MSN1dOpinion
Top Research Reports for Visa, ServiceNow & Progressive
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), ServiceNow, Inc. (NOW) ...
As part of Amedisys Hospice’s We Honor Veterans Program, Patricia Brewer gives Ned Melancon a Navy pin during his 100th ...
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A scientific study, whose results are published in the journal Nature Medicine, reveals how to reach 70 years of age without ...
RBC Capital analyst Ben Hendrix maintained a Buy rating on Amedisys (AMED – Research Report) yesterday and set a price target of $100.00.Stay ...